A detailed history of Covestor LTD transactions in Atri Cure, Inc. stock. As of the latest transaction made, Covestor LTD holds 5 shares of ATRC stock, worth $130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 4 25.0%
Holding current value
$130
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$19.86 - $29.09 $19 - $29
1 Added 25.0%
5 $0
Q1 2024

May 10, 2024

BUY
$28.21 - $37.78 $28 - $37
1 Added 33.33%
4 $0
Q3 2023

Nov 13, 2023

SELL
$41.12 - $57.73 $41 - $57
-1 Reduced 25.0%
3 $0
Q1 2023

May 15, 2023

SELL
$35.87 - $47.22 $143 - $188
-4 Reduced 50.0%
4 $0
Q3 2022

Nov 14, 2022

BUY
$38.25 - $52.62 $114 - $157
3 Added 60.0%
8 $0
Q2 2022

Aug 10, 2022

SELL
$35.1 - $66.01 $70 - $132
-2 Reduced 28.57%
5 $0
Q1 2022

May 13, 2022

SELL
$57.43 - $71.39 $57 - $71
-1 Reduced 12.5%
7 $0
Q4 2021

Feb 10, 2022

BUY
$63.4 - $87.14 $507 - $697
8 New
8 $1,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.21B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.